Summary
In order to investigate the retrograde spread in the colon and its relationship to the extent of the diseased area, the authors evaluated a 100ml enema of mesalazine (5-aminosalicylic acid, ‘Pentasa’) 1g in a consecutive series of 30 patients with ulcerative colitis.
The enema was labelled with 10 MBq 99mtechnetium-human serum albumin microcolloid. Sequential scintigraphic imaging was performed in all patients, and the results compared with the extension of the disease as found by colonoscopy. If the enema reached the entire affected area it was interpreted as ‘topically adequate’.
In 80% of the patients there was retrograde spread of the enema beyond the rectosigmoid, thus reaching the affected area in ulcerative colitis. No relationship was found between the extent of dispersion of the enema and the time of defecation prior to scintigraphy.
The authors conclude that a 100ml ‘Pentasa’ enema may be adequate for treatment of ulcerative colitis extending up to the splenic flexure.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Azad Khan AK, Piris J, Truelove SC. An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet 2: 892–895, 1977
Campieri M, Lanfranchi GA, Bazzocchi G, Brignola C, Sarti F, et al. Treatment of ulcerative colitis with high dose 5-amino salicylic acid enemas. Lancet 2: 270–271, 1981
Campieri M, Lanfranchi GA, Brignola G, Gionchetti P, Minguzz MR, et al. Retrograde spread of 5-aminosalicylic acid enemas in patients with active ulcerative colitis. Diseases of the Colon and Rectum 29: 108–110, 1986
Danish 5-ASA Group. Topical 5-aminosalicylic acid versus prednisolone in ulcerative proctosigmoiditis. Digestive Diseases and Sciences 6: 598–602, 1987
Farthing MJC, Rutland MD, Clark ML. Retrograde spread of hydrocortisone containing foam given intrarectally in ulcerative colitis. British Medical Journal 2: 822–824, 1979
Hardy JG, Lee SW, Clark AG, Reynolds JR. Enema volume and spreading. International Journal of Pharmaceutics 31: 151–155, 1983
Hay DJ. Spreading characteristics of proprietary rectal steroid preparations. In Wilson et al. (Eds) Radionuclide imaging in drug research, Croom Helm, London, 1982
Hay DJ, Sharma H, Irving MH. Spread of steroid-containing foam after intrarectal administration. British Medical Journal 2: 1751–1753, 1979
Mulder CJJ, Tytgat GNJ, Wiltink EHH, Houthoff H-J. Comparison of 5-aminosalicylic acid (3g) and prednisolone phosphate sodium enemas (30mg) in the treatment of distal ulcerative colitis. Scandinavian Journal of Gastroenterology 23: 1005–1008, 1988
Swarbrick ET, Loose H, Lennard-Jones JE. Enema volumes an important factor in successful topical corticosteroid treatment of colitis. Proceedings of the Royal Society of Medicine 67: 753–754, 1974
van Buul MMC, Mulder CJJ, Wiltink EHH, van Royen EA, Tytgat GNJ. Retrograde spread of therapeutic enemas in patients with inflammatory bowel disease. Hepato-Gastroenterology 36: 199–201, 1989
van Hees PAM, Bakker JH, van Tongeren JHM. Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis; a study to determine the active therapeutic moiety of sulphasalazine. Gut 21: 632–635, 1980
Weber J, Rasmussen CE. Stralingsbescherming, p. 90, Delftse Uitgevers Maatschappij b.v., Delft, 1985
Wood E, Wilson CG, Hardy JG. The spreading of foam and solution enemas. International Journal of Pharmaceutics 25: 191–197, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tiel-van Buul, M.M.C., Mulder, C.J.J., van Royen, E.A. et al. Retrograde Spread of Mesalazine (5-Aminosalicylic Acid)-Containing Enema in Patients with Ulcerative Colitis. Clin. Pharmacokinet. 20, 247–251 (1991). https://doi.org/10.2165/00003088-199120030-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-199120030-00006